New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2013
10:00 EDTAMTG, PRI, GPN, CYS, QLIK, MVO, HILL, BBT, BCRX, PKI, MAKO, DOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: BB&T (BBT) upgraded to Buy from Neutral at Compass Point... CYS Investments (CYS) upgraded to Buy from Neutral at Compass Point... Dominion (D) upgraded to Overweight from Neutral at Atlantic Equities... Dot Hill Systems (HILL) upgraded to Buy from Hold at Needham... Global Payments (GPN) upgraded to Buy from Neutral at Nomura... MAKO Surgical (MAKO) upgraded to Buy from Neutral at Mizuho... MV Oil Trust (MVO) upgraded to Market Perform from Underperform at Raymond James... Primerica (PRI) upgraded to Outperform from Market Perform at Raymond James... Qlik Technologies (QLIK) upgraded to Overweight from Equal Weight at Evercore... PerkinElmer (PKI) upgraded to Strong Buy from Buy at ISI Group... Apollo Residential Mortgage (AMTG) upgraded to Overweight from Neutral at JPMorgan... BioCryst (BCRX) upgraded to Buy from Hold at MLV Equity.
News For BBT;CYS;D;HILL;GPN;MAKO;MVO;PRI;PKI;QLIK;AMTG;BCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
12:33 EDTBBTBB&T management to meet with Jefferies
Subscribe for More Information
September 2, 2015
10:00 EDTBBTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:51 EDTBBTBB&T upgraded to Outperform at Baird
As reported previously, Baird upgraded BB&T to Outperform from Neutral. The firm cited compelling valuation, less earnings risk, and better business mix for a low growth, low interest rate environment. Baird maintained its $40 price target on BB&T shares.
06:10 EDTBBTBB&T upgraded to Outperform from Neutral at Baird
September 1, 2015
10:51 EDTBCRXBioCryst, ASPR/BARDA amend agreement for development of BCX4430
BioCryst Pharmaceuticals said in a regulatory filing that on August 28, the company and the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response amended the Agreement dated March 27 for the continued development of BCX4430 as a potential treatment for diseases caused by RNA pathogens, including filoviruses. Pursuant to this amendment, ASPR/BARDA exercised an option under the Agreement to authorize $4.2M of funding to enable non-clinical NDA-enabling toxicology studies and obligated an additional $1.2M of new funding to support previously authorized drug substance and drug product cGMP manufacturing by U.S. suppliers for non-clinical and clinical activities. The execution of the Amendment represents an additional $5.4M in funding BioCryst to support BCX4430 drug manufacturing and toxicology studies, and increases the total potential value of the contract to $36.2M. The period of performance under the exercised options extends through April 14, 2017, while the period of performance under the base period of the contract remains unchanged, extending through September 30, 2016.
August 28, 2015
13:56 EDTPRITorchmark, Primerica could be targets for Japanese buyers, dealReporter says
Subscribe for More Information
August 27, 2015
10:00 EDTPKI, QLIKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:59 EDTBBTBB&T sees Q3 effective tax rate roughly 30%
Subscribe for More Information
07:41 EDTQLIKQlik Technologies initiated with a Buy at Nomura
Subscribe for More Information
August 26, 2015
16:20 EDTPKIPerkinElmer initiated with a Buy at Cantor
Target $62.
10:00 EDTBBTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:26 EDTBBTBB&T upgraded on valuation at BMO Capital
Subscribe for More Information
06:52 EDTBBTBB&T upgraded to Outperform from Market Perform at BMO Capital
Subscribe for More Information
August 25, 2015
09:35 EDTBBTBB&T upgraded to Long-Term Buy from Neutral at Hilliard Lyons
Subscribe for More Information
August 21, 2015
16:34 EDTHILLMarket enters correction territory in worst week in four years
For the week, stocks plummeted amid concerns about a slowing Chinese economy and declining oil prices. MACRO NEWS: Monday, the Empire State manufacturing index crashed to -14.92 in August after rebounding to 3.86 in July from June's -1.98. The consensus estimate was 4.75, and the surprising drop puts the index at its lowest point since April 2009... Meanwhile, the NAHB homebuilder sentiment index rose to 61 in August from 60 in June, matching consensus estimates... Tuesday, July housing starts edged up 0.2% to 1.206M, beating consensus estimates for 1.180M in the best reading since October 2007. Building permits, however, fell 16.3% to 1.119M against expectations for 1.230M, while single family starts rose 12.8% and multifamily numbers fell 17.0%... Wednesday, the July consumer price index edged up 0.1% against expectations for 0.2% reading. The core reading, which excludes food and energy, also came in at 0.1% versus consensus estimates of 0.2%... Meanwhile, FOMC minutes showed no definitive indication of a September rate hike... Thursday, initial jobless claims rose to 277,000 from a revised 273,000, bringing the 4-week moving average to 271,500... The Philadelphia Fed index rose 2.6 points to 8.3 in August, beating expectations for a 7.5 reading... Friday, the PMI Manufacturing Index Flash for August came in at a level of 52.9, below the prior level of 53.8 and the consensus level of 54.2. COMPANY NEWS: Monday, Liberty Interactive (QVCA) announced an agreement to acquire zulily (ZU) for $18.75 per share in a deal valuing the online shopping site at $2.4B. The acquisition will be attributed to Liberty's QVC tracking stock, though the companies specified that QVC and zulily will operate as separate brands... Amazon (AMZN) founder and CEO Jeff Bezos downplayed a recent New York Times critique of the company's workplace practices, telling employees in an email that "the article doesn't describe the Amazon I know or the caring Amazonians I work with every day..." Tuesday, Wal-Mart (WMT) cut its full year earnings outlook, with company executives on a subsequent conference call expressing confidence in China but noting that Brazil and U.K. remain challenging markets for the company... Wednesday, Seagate Technology (STX) agreed to acquire Dot Hill Systems (HILL) for $9.75 per share, noting that it expects the deal to be non-GAAP EPS accretive in fiscal 2016... Thursday, Valeant (VRX) agreed to acquire Sprout Pharmaceuticals for roughly $1B in cash plus a profit-sharing agreement, adding that it expects to bring the company's recently-approved female sexual dysfunction drug Addyi to the U.S. by Q4... Friday, Steiner Leisure (STNR) entered into a definitive merger agreement where an affiliate of Catterton will acquire all of the outstanding shares of Steiner for $65 per share in cash. INDEXES: For the week, the Dow lost about 5.79% to close at 16,459.75, the Nasdaq declined about 6.71% to close at 4,706.04, and the S&P 500 fell about 5.73% to close at 1,970.89.
16:06 EDTHILLDot Hill Systems revises manufacturing pact with Foxconn
On August 1 , the company restated and revised the Manufacturing and Purchase Agreement originally entered into with Hon Hai Precision Industry, and its parents, subsidiaries and affiliate companies, Foxconn, in September 2008 and previously amended with Amendments No. 1 through 7 in 2009, 2013, 2014 and 2015. The Restated and Revised Amendment extends the agreement with Foxconn for a three year period to September 1, 2018.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use